68Ga-ABY-025: Clinical Trials

2 trials of 68Ga-ABY-025, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 12Completed 1, Terminated 1
Phase 21Completed 1

Follow 68Ga-ABY-025: new trials by email Literature Review of 68Ga-ABY-025 trials Research Report on 68Ga-ABY-025

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
PET Study of Breast Cancer Patients Using [68Ga]ABY-025
[68Ga]ABY-025 - Breast Cancer
Phase 1 / Phase 2CompletedBiomedical Radiation Sciences162013-04-012015-01-13
HER2 PET Imaging in Breast Cancer Patients Using [68GA]ABY-025
Radiolabeled [68Ga]ABY-025 - HER2-positive Breast Cancer
Phase 1TerminatedDorte Nielsen22011-08-012020-10-05

Conditions studied

Breast Neoplasms (2)

Sponsors

Biomedical Radiation Sciences (1)  ·  Dorte Nielsen (1)

Countries

Denmark (1)  ·  Sweden (1)

Top investigators

Henrik Lindman, MD, PhD (1)  ·  Malgorzata K Tuxen, MD, P.hd. (1)